We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$439M
AUM Growth
+$22.7M
Cap. Flow
+$1.23M
Cap. Flow %
0.28%
Top 10 Hldgs %
18.86%
Holding
332
New
121
Increased
28
Reduced
53
Closed
100

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.29M
2
AXP icon
American Express
AXP
+$7.22M
3
CVS icon
CVS Health
CVS
+$4.98M
4
DVN icon
Devon Energy
DVN
+$4.92M
5
AMP icon
Ameriprise Financial
AMP
+$4.87M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$8.18M
2
CB icon
Chubb
CB
+$7.62M
3
NSC icon
Norfolk Southern
NSC
+$7.16M
4
PSA icon
Public Storage
PSA
+$7.08M
5
CPB icon
Campbell Soup
CPB
+$6.99M

Sector Composition

Rank Sector Weight
1 Technology 16.64%
2 Financials 14.44%
3 Healthcare 13.99%
4 Industrials 11.57%
5 Energy 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDR
301
DELISTED
Waddell & Reed Financial, Inc.
WDR
-5,875
Closed -$433K
AMTD
302
DELISTED
TD Ameritrade Holding Corp
AMTD
-113,760
Closed -$3.86M
ENT
303
DELISTED
Global Eagle Entertainment Inc.
ENT
-920
Closed -$363K
MINI
304
DELISTED
Mobile Mini Inc
MINI
-4,525
Closed -$196K
AGN
305
DELISTED
Allergan plc
AGN
-19,290
Closed -$3.97M
ISCA
306
DELISTED
International Speedway Corp
ISCA
-10,300
Closed -$350K
NCI
307
DELISTED
Navigant Consulting, Inc.
NCI
-10,420
Closed -$194K
TYPE
308
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-6,380
Closed -$192K
BKS
309
DELISTED
Barnes & Noble
BKS
-18,304
Closed -$251K
RDC
310
DELISTED
Rowan Companies Plc
RDC
-7,610
Closed -$256K
ITG
311
DELISTED
Investment Technology Group Inc
ITG
-11,380
Closed -$230K
FCRE
312
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
-1,850
Closed -$146K
LVNTA
313
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
-89,744
Closed -$2.87M
SCMP
314
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
-6,840
Closed -$49K
BRCD
315
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
-22,560
Closed -$239K
PWE
316
DELISTED
Penn West Energy Petroleum Ltd
PWE
-32,775
Closed -$274K
IM
317
DELISTED
Ingram Micro
IM
-10,320
Closed -$305K
EPIQ
318
DELISTED
EPIQ SYSTEMS INC
EPIQ
-11,670
Closed -$159K
SYA
319
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
-3,360
Closed -$67K
PVA
320
DELISTED
PENN VIRGINIA CORP
PVA
-39,650
Closed -$693K
REMY
321
DELISTED
REMY INTL INC NEW COMMON
REMY
-3,655
Closed -$86K
LTM
322
DELISTED
LIFE TIME FITNESS INC
LTM
-3,740
Closed -$180K
ANV
323
DELISTED
Allied Nevada Gold Corp
ANV
-28,840
Closed -$124K
SWY
324
DELISTED
SAFEWAY INC
SWY
-2,496
Closed -$83K
CMCSK
325
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
-1,365
Closed -$67K

Similar funds

C.M. Bidwell & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, C.M. Bidwell & Associates held 332 positions worth $439M, up 5.5% from $416M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

C.M. Bidwell & Associates's Q2 2014 filing shows 121 new, 28 increased, 53 reduced and 100 closed positions. Its largest new stake was Gilead Sciences: 93,610 shares worth $7.76M. The largest sale was Charles Schwab, an estimated $8.18M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2014 buy was Gilead Sciences: 93,610 shares worth $7.76M.
  • C.M. Bidwell & Associates added most to CVS Health in Q2 2014, an estimated $4.98M increase.
  • C.M. Bidwell & Associates's biggest Q2 2014 reduction was Chubb, cutting an estimated $7.62M.
  • C.M. Bidwell & Associates fully exited Charles Schwab in Q2 2014, selling an estimated $8.18M.
  • C.M. Bidwell & Associates's ten largest holdings make up 19% of its $439M portfolio in Q2 2014.
  • C.M. Bidwell & Associates opened 121 new positions and closed 100 in Q2 2014.
  • C.M. Bidwell & Associates's portfolio value rose 5.5% quarter-over-quarter to $439M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2014, filed 12 Aug 2014.